alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 23.2


INDEPENDENT AUDITORS' CONSENT

The Board of Directors
First National Lincoln Corporation:

We consent to the incorporation by reference in the Registration Statement on
Form S-8 of First National Lincoln Corporation of our report dated January 30,
2004, with respect to the consolidated balance sheets of First National Lincoln
Corporation and Subsidiary as of December 31, 2003 and 2002, and the related
consolidated statements of income, changes in shareholders' equity and cash
flows for each of the three years in the three-year period ended December 31,
2003, which report appears in the December 31, 2003 annual report on Form 10-K
of First National Lincoln Corporation, and to the reference to our firm under
the heading "Experts" in the Registration Statement.

We consent to the incorporation by reference in the Registration Statement on
Form S-8 of First National Lincoln Corporation of our report dated November 5,
2004, with respect to the interim consolidated financial information of First
National Lincoln Corporation and Subsidiary as of September 30, 2004 and 2003,
and for the three- and nine-month periods then ended.


/s/ BERRY, DUNN, MCNEIL & PARKER

Berry, Dunn, McNeil & Parker
Portland, Maine
February 3, 2005
Exhibit 23.1








Consent of Sidley Austin LLP (included as part of Exhibit 5.1).
NON RECOURSE PROMISSORY NOTE

$____________.00 _________, 19___
La Jolla, California

FOR VALUE RECEIVED, ________________ (hereinafter "Maker") promises to pay to
the order of OCET Corporation, a Delaware corporation (hereinafter "Holder") at
1200 Prospect, Suite 325, La Jolla, California 92037 or at such other place as
may be designated in writing by Holder, the principal sum of $________.00 plus
interest thereon at the higher of eight percent (8%) simple interest per year or
that interest rate below which the IRS would impute income to Maker. All
principal and interest shall be due and payable on a date five years from the
date hereof.

Maker shall have the right at any time to repay any amount of principal or
interest due under this Note, without penalty. All repayments of principal shall
be applied to the latest principal maturity or maturities then remaining unpaid.

If default be made in the payment of the principal and interest, when due,
or in the payment of any other sum required to be paid under this Note, and the
default is not cured within thirty (30) days after written notice from Holder to
Maker, then the principal sum remaining unpaid hereunder, together with accrued
interest thereon, shall thereupon become immediately due and payable at the
option of Holder. Failure to exercise the option to accelerate the obligations
of this Note shall not constitute a waiver of the right to exercise the same in
the event of any subsequent default.

This Note is secured by OCET common stock purchased by Maker under a
Warrant. As provided in the Warrant and also herein, any and all liability of
Maker arising under this Note, or any prior Note, or arising under the Warrant,
is limited to the OCET common stock, which is and shall be the sole and only
security for this Note. By accepting this Note, Holder agrees that no deficiency
judgement may be sought or obtained against Maker.

By accepting this Note, Holder further agrees that it will not declare a
default nor exercise any of the rights contained in the Assignment of the Stock
as Security unless Maker has failed to comply with the terms of this Note.

------------------------------
Maker
From: bjtuttle@live.com

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 1:13:02 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Bill Tuttle

Colorado Springs, CO 80907
From: rdeh471@verizon.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 12:57:17 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

David Helwig

Northumberland, PA 17857
From: beckysmiles@comcast.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 12:21:29 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Rebecca Adkins

New Haven, MI 48048
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Century
Properties Fund XX 1997 Year-End 10-KSB and is qualified in its entirety by
reference to such 10-KSB filing.
</LEGEND>
<CIK> 0000736909
<NAME> CENTURY PROPERTIES FUND XX
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                           7,314
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0<F1>
<PP&E>                                          49,623
<DEPRECIATION>                                (18,012)
<TOTAL-ASSETS>                                  40,221
<CURRENT-LIABILITIES>                                0<F1>
<BONDS>                                         47,753
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                     (8,153)
<TOTAL-LIABILITY-AND-EQUITY>                    40,221
<SALES>                                              0
<TOTAL-REVENUES>                                 7,724
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                 6,305
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,511
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,092)
<EPS-PRIMARY>                                  (17.31)<F2>
<EPS-DILUTED>                                        0
<FN>
<F1>Registrant has an unclassified balance sheet.
<F2>Multiplier is 1.
</FN>


</TABLE>
No. 187.

No. 188.

No. 189.

No. 194.

#### Isaacs et al. *v.*United States; Larrick *v.*United States; Jeffords *v.*United States; and Ossanna *v.*United States.

*Benedict Deinard*and *Melvin H. Siegel*for petitioners in No. 187.

*Robert J. King*for petitioner in No. 188. *John E. Wasche*for petitioner in No. 189.

*James M. Landis*for petitioner in No. 194. *Solicitor General Cox, Assistant Attorney General Miller, Beatrice Rosenberg*and *Sidney M. Glazer*for the United States.

C. A. 8th Cir. Certiorari denied.
From: g-cward@cox.net

To: E-OHPSCA2713.EBSA

Subject: Comment: RIN 1210-AB44

Date: Wednesday, September 07, 2011 12:44:52 PM

To Whom It May Concern:

I am writing today to ask in the strongest way possible that you rescind the unjust and coercive

mandate that all "contraceptives" and sterilization procedures be covered by private health insurance

with no co-pay to patients. If you do not reverse course I ask you to expand conscience protections for

any organizations that provide individual and group insurance and have moral or religious objections. I

strongly oppose the government forcing free insurance coverage on Americans especially for drugs and

devices that I oppose because some of these can cause an abortion (such as ella and Plan B).

I also ask you to reconsider your definition of religious employer and offer an authentic conscience

protection for any organization and business that has moral or religious objection to providing such

insurance to their employees. This legal mandate clearly violates the spirit of conscience laws which

prohibit government discrimination against those who object to various health services on moral or

religious grounds. The definition of "religious employer" in the regulation is so narrow as to only include

churches, but will still mean that a host of businesses and organizations that have conscience objections

will be required to choose between either violating their conscience or not being able to offer employees

health insurance.

Please protect the conscience rights of insurers, providers and people like me who object to being

forced by the federal government to offer or subsidize contraceptives and sterilization services, especially

when some of these drugs can take the life of early unborn children. No Americans should be forced by

the federal government to essentially subsidize services they object to. I again urge you in the strongest

way possible to reverse course and remove contraceptives and sterilizations from the list of mandatory

preventive services.

Sincerely,

Carolyn Ward

Manhattan, KS 66502
EXHIBIT 10.3

AMENDMENT TO CHANGE OF CONTROL AGREEMENT

THIS AMENDMENT (the "Amendment") is made as of the 31st day of December, 2008, by and between inTEST Corporation, a Delaware corporation ("inTEST") and Daniel J. Graham ("Executive").

WHEREAS, inTEST and Executive entered into an agreement, dated May 5, 2008, (the "Agreement") which may be subject to Section 409A of the Internal Revenue Code of 1986, as amended (the "Code");

WHEREAS, it is in the best interests of Executive and inTEST to amend the Agreement to comply with final regulations issued by the Internal Revenue Service under Section 409A of the Internal Revenue Code of 1986, as amended, (the "Code") in order for Executive to avoid the adverse tax consequences that would arise from a failure to comply with Code Section 409A, including the imposition of an additional 20% excise tax on payments provided thereunder;

NOW, THEREFORE, the parties, intending to be legally bound, agree to amend the Agreement as of January 1, 2009 by adding the following new Section 20 thereto:

"20.	COMPLIANCE WITH CODE SECTION 409A.For purposes of this Agreement, Executive's termination of employment shall mean Executive's "separation from service" as defined under Code Section 409A. Each payment under this Agreement that is determined to be subject to Section 409A shall be treated as a separate payment. In no event may Executive, directly or indirectly, designate the calendar year of any payment to be made under this Agreement. Notwithstanding any provision of this Agreement to the contrary, if Executive is a "specified employee" (as defined in Section 409A of the Code) as of his "separation from service" (as defined in Section 409A of the Code), then the payment of any amounts payable hereunder that are subject to Section 409A of the Code shall be postponed in compliance with Section 409A (without any reduction in such payments ultimately paid or provided to Executive) until the first payroll date that occurs after the date that is six (6) months following Executive's "separation from service." Any such postponed payments shall be paid in a lump sum to Executive on the first payroll date that occurs after the date that is six (6) months following Executive's "separation from service." If Executive dies during the postponement period prior to the payment of the postponed amount, the amounts withheld on account of Section 409A shall be paid to Executive's estate within sixty (60) days after the date of his death."

IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the day and year first written above.

inTEST CORPORATION

By:   /s/ Alyn R. Holt
      Alyn R. Holt, Chairman of the Board

EXECUTIVE

/s/ Daniel J. Graham
Daniel J. Graham
Exhibit 10.1


 


AMENDMENT TO

SERIES X WARRANT


 


This AMENDMENT to
SERIES X warrant (this “Amendment”), dated as of December 13, 2012, is made by and between Navidea Biopharmaceuticals,
Inc. (f/k/a Neoprobe Corporation), a corporation organized under the laws of Delaware (the “Company”), and Platinum-Montaur
Life Sciences, LLC (“Platinum”).


 


BACKGROUND


 


WHEREAS,
on or about April 18, 2008, the Company issued to Platinum a Series X Warrant (#WX08-001) to Purchase 8,333,333 Shares of
the Company’s Common Stock, which Series X Warrant was amended and restated on or about July 24, 2009 (#WX08-001A), which
Series X Warrant was then replaced on or about July 2, 2012 to reflect a change in the Company's name (#WX08--002) (as so amended
and replaced the “Series X Warrant”); and


 


WHEREAS, as is set
forth herein, the Company and Platinum wish to amend certain of the terms of the Series X Warrant.


 


AGREEMENT:


 


NOW, THEREFORE, for
good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto have agreed as
follows.


 


		1.	Amendment to Series X Warrant. 



 


Section
1 of the Series X Warrant is amended to read in its entirety as follows:


 


1.Term.
The right to subscribe for and purchase shares of Warrant Stock represented hereby shall commence on April 18, 2008 and shall expire
at 5:00 p.m., Eastern Time, on December 31, 2013 (the “Term”).


 


		2.	Continuing Effect.Except
as expressly set forth herein, this Amendment shall not alter, modify, amend or in any way affect any of the terms, conditions,
covenants, obligations or agreements contained in the Series X Warrant. Any capitalized terms not defined herein shall have that
meaning as set forth in the Series X Warrant. This Amendment shall be governed by the laws of the State of New York, without regard
to the conflict of law provisions thereof.



 


		3.	Counterparts.This
Amendment may be executed in any number of counterparts, which taken together shall be deemed to constitute one and the same agreement
and each of which individually shall be deemed to be an original, with the same effect as if the signature on each counterpart
were on the same original.



 






    	 



    	 



    

Amendment to Warrant WX08-002


December 13, 2012


 


 


IN WITNESS WHEREOF, the
parties hereto have executed this Amendment on the day and year first above written.


 


	 	NAVIDEA BIOPHARMACEUTICALS, INC.
	 	 
	 	 
	 	By: 	/s/ Brent L. Larson
	 	 	Name: Brent L. Larson
Title: Senior Vice President and CFO
	 	 	 
	 	 	 
	 	PLATINUM-MONTAUR LIFE SCIENCES, LLC
	 	 	 
	 	 	 
	 	By:	/s/ Michael Goldberg
	 	 	Name: Michael Goldberg
Title: Portfolio Manager



 



    	2
EXHIBIT 31.2

CERTIFICATION OF TREASURER

I, Robert F. Aufenanger, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Excelsior Private Equity Fund II, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for the periods presented in this report;

4. The registrants other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;

b) evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

c) disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most
recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and

5. The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record,
process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrants internal control over financial reporting.

Date: June 14, 2006



|                               
|-------------------------------
|/s/ Robert F. Aufenanger       
|Robert F. Aufenanger, Treasurer
|